NYSE: CVX · Chevron CorporationEnhanced Equity Research · May 31, 2026
Equity Research Report
Analysis by Joseph Lefcoe
Enhanced Equity Research — Chevron Corporation (CVX)
39-Year Dividend AristocratHess + Guyana Production EngineFortress Balance Sheet (0.2x D/E)

CVX

Chevron Corporation — Enhanced Equity Research
Current Price
$182.46
Market Cap
361B
52-Week High
214.71
52-Week Low
136.43
BUY
PT $211
+16% upside · Med-High conviction

Hess-Powered Production, A 39-Year Dividend Streak, And A Softening Oil Tape

Chevron (CVX) trades at $182.46, in the upper half of its $136-$215 52-week range after a strong year driven by the Hess integration. Q1 2026 delivered adjusted EPS of $1.41, a 45% beat versus the $0.97 consensus, on revenue of $48.6B. Net production jumped to 3.86M BOE/d, +15% YoY — the first full quarter of legacy Hess assets plus Permian and Guyana growth. The crown jewel for a dividend holding: 39 consecutive years of dividend increases, a Dividend Aristocrat now yielding ~3.9% on a $7.12 annual payout after a 4% January hike. Chevron returned $6.0B to holders in Q1 (16th straight quarter above $5B) and has booked $1.5B of its $2B Hess synergy target. The swing factor is oil: Brent near $106 today is forecast to fade toward $89-96 over 2026, pressuring a ~104% reported payout ratio that FCF still covers. Street stays Buy with a ~$216 average target.

Q1 2026 Snapshot — Production +15% YoY on the first full Hess quarter, adjusted EPS beating by 45%, with $6.0B returned to shareholders.

Adj. EPS (Q1'26)
$1.41
Beat $0.97 est by ~45% · -35% YoY
Revenue (Q1'26)
$48.6B
Below ~$51.4B est on weaker pricing
Net Production
3.86M BOE/d
+15% YoY · first full Hess quarter
Dividend Yield
3.9%
$7.12/yr · 39 yrs of increases
Cash Returned (Q1)
$6.0B
16th straight quarter above $5B
Hess Synergies
$1.5B
of $2B target realized by Mar'26
FY26 Production Growth
+7-10%
Capex guided $18B-$19B
Forward P/E
~19x
Trailing ~27x · 0.2 debt/equity

Quarterly Revenue Trend

$45.8B
Q2'25
$49.7B
Q3'25
$46.9B
Q4'25
$48.6B
Q1'26

Integrating Hess, Compounding the Dividend, Defending FCF Through the Oil Cycle

+15%
Q1'26 Production Growth
3.86M BOE/d on full Hess contribution
39 yrs
Consecutive Dividend Increases
Dividend Aristocrat · ~3.9% yield
$1.5B
Hess Synergies Realized
of $2B target · >$1B annual run-rate by YE26
Jul 2025
Hess Acquisition Closes
Chevron completes the Hess deal, adding a 30% stake in Guyana's Stabroek Block and Bakken assets; John Hess joins the board; HQ relocates to Houston.
Jan 2026
4% Dividend Hike
Quarterly dividend raised to $1.78 ($7.12 annualized), extending the increase streak to 39 consecutive years and cementing Dividend Aristocrat status.
Feb 2026
Q4 2025 + FY2025
Q4 adj EPS $1.52 beat $1.45; FY2025 returned $27.1B to holders ($12.8B dividends + $12.1B buybacks). Adjusted FCF $4.2B in Q4.
May 1, 2026
Q1 2026: Adj EPS $1.41 (+45% beat)
Production 3.86M BOE/d (+15% YoY); $6.0B returned (16th straight quarter >$5B); $1.5B of $2B Hess synergies booked; FY26 output guided +7-10%, capex $18-19B.
May 2026
Oil Spike Then Fade
Brent spiked toward $138 in April on Strait of Hormuz disruption, easing toward ~$106 in May; EIA/JPM see FY26 averaging ~$90-96 as Mideast supply resumes.

Forward Estimates, Surprises & Insider Activity

Forward Earnings Estimates

FY+1 EPS Consensus$8.20 (FY2026e)
FY+2 EPS Consensus$8.90 (FY2027e)
PEG Ration/m (cyclical)
Forward P/E~19x
EPS Revisions (90d)↑9 ↓11 (Mixed — near-term estimates trimmed on the projected oil-price fade into late 2026, partly offset by Hess volume and synergy upgrades.)
Guidance AccuracyReliable — production and capex guides (FY26 +7-10% output, $18-19B capex) consistently met; adjusted-EPS beats in each of the last 5 quarters despite revenue softness.

Earnings Surprise Track Record

Q2'25 Est: $1.70 Act: $1.77 +4.1%
Q3'25 Est: $1.66 Act: $1.85 +11.4%
Q4'25 Est: $1.45 Act: $1.52 +4.8%
Q1'26 Est: $0.97 Act: $1.41 +45.4%
Beat RateBeat on adjusted EPS in 4 of last 4 quarters (revenue missed in all 4)

Insider Activity (90 Days)

Net Buying/SellingMinimal
Sell/Buy RatioRoutine (10b5-1 disposals)
Neutral
Insider activity over the trailing 90 days is limited and largely routine (option-exercise-related and pre-arranged 10b5-1 sales), consistent with a mega-cap. No material discretionary buying or selling signal; sentiment driver is the dividend and oil tape, not insider flow.

Relative Valuation vs. Competitors

CompanyFwd P/EDiv YieldProduction GrowthDebt/Equity
Chevron19x3.9%+7-10%0.2x
ExxonMobil14x3.5%+3-4%0.2x
ConocoPhillips13x4.7%+mid-single0.4x
Shell9x3.8%+low-single0.4x
CVX carries a premium forward P/E (~19x) versus XOM (~14x), COP (~13x) and SHEL (~9x), reflecting the post-Hess production step-up and Guyana optionality. Its ~3.9% yield sits between XOM's 3.5% and COP's 4.7%, while a sector-low ~0.2x debt/equity and 39-year increase streak make CVX the most defensive dividend in the majors. The premium is the price of growth visibility; bears note XOM offers similar quality cheaper.

Price Targets & Scenarios

ScenarioPrice TargetAssumptionsProbability
Bull Case$245Brent holds $100+ on sustained Mideast supply tightness; Hess/Guyana volumes and the full $2B+ synergy run-rate drive record FCF; buybacks accelerate and the dividend compounds — multiple re-rates toward XOM as a best-in-class integrated.30%
Base Case$211Brent normalizes to ~$90-96 over 2026; production grows 7-10% with Hess fully integrated; ~$7.12 dividend remains comfortably FCF-covered; buybacks moderate but continue. Stock tracks a high-teens forward multiple.45%
Bear Case$150Brent slides toward $79 in 2027 as Mideast and OPEC+ supply floods back; weaker realizations squeeze the ~104% reported payout, buybacks are trimmed to protect the balance sheet, and the energy complex de-rates with the cycle.25%

Probability-Weighted Target: $211 (+16% from current price)

$211
Weighted
Bull $24530%
Base $21145%
Bear $15025%

Analyst Consensus

Consensus (25 analysts)
$216
Buy / Average
Street Low
$170
Hold / Cautious
Street High
$236
Buy / Bullish
Median (42 analysts)
$220
Buy / Maintained
Buy consensus across ~25-42 analysts. Average 12-month target ~$216 implies roughly +18% upside from $182.46; range spans $170 (-7%) to $236 (+29%). Sell ratings are rare in the core panel.

Key Levels & Options Intelligence

S/RSupport & Resistance

52-Week High
$214.71
Street Avg Target
$216.09
Resistance
$196.00
Current Price
$182.46
200-Day MA
$173.18
Support
$165.00
52-Week Low
$136.43

OptOptions & Sentiment

  • Implied Volatility (30D): ~28% (oil-driven)
  • IV Percentile: ~70% (elevated on Mideast risk)
  • Put/Call Ratio (OI): 0.78 · call-tilted
  • Trend vs 200-DMA: Above $173 · bullish
  • Trend vs 50-DMA: Below ~$193 · short-term cooling
  • Beta: ~0.9 · defensive vs market
  • 30D IV Skew: Put-skewed (oil-downside hedging)
  • Dividend Support: ~3.9% yield cushions downside

Systematic Conviction Score: 79/100 (Med-High)

80
Analyst Alignment
30%
78
FCF Visibility
25%
75
Catalyst Clarity
20%
70
Valuation Safety
15%
90
Mgmt Quality
10%
Buy-rated with ~+18% to the average target, best-in-class capital discipline and a 39-year dividend streak underpin high management quality. FCF covers the dividend at current strip and Hess/Guyana give clear volume catalysts; tempered by an oil tape forecast to soften into late 2026 and a premium multiple versus cheaper majors.

Risk Assessment & Insider Signals

!Risk Factors

  • Oil price reversion toward $79-90: Brent's April spike toward $138 on the Strait of Hormuz disruption is set to unwind; EIA sees ~$89 in Q4'26 and ~$79 in 2027 as Mideast/OPEC+ barrels return. Lower realizations directly compress upstream earnings and FCF.
  • Elevated ~104% reported payout ratio: The $7.12 dividend is covered by levered FCF (~$13.2B vs ~$12.8B dividends) at current strip, but a sustained slide to sub-$80 Brent would push payout above FCF and force buyback cuts to defend the streak.
  • Hess integration / Guyana execution: Realizing the final $0.5B of the $2B synergy target and ramping Stabroek volumes on schedule is core to the thesis; arbitration history around the Guyana stake and project timing add execution risk.
  • Premium valuation vs cheaper majors: At ~19x forward and ~27x trailing, CVX trades above XOM (~14x), COP and SHEL. Any production or synergy disappointment removes the premium and the stock de-rates toward the peer group.
  • Energy-transition / demand risk: Structural EV and efficiency gains plus policy pressure could erode long-run oil demand, weighing on terminal value and capital-allocation flexibility even as near-term cash flows stay robust.
  • Geopolitical / regulatory shocks: Concentrated exposure to Permian, Guyana, Kazakhstan (TCO) and the Gulf means a single sanction, tax, or operational event can swing volumes and earnings sharply in either direction.

OOwnership & Insider Signals

  • Institutional ownership ~74%: Roughly 73.6% of shares held by institutions, with ~25.9% retail and ~0.5% insiders — a deep, blue-chip holder base typical of a mega-cap dividend payer.
  • Top holders — index giants plus Berkshire: Largest holders include Vanguard (~9.2%, 183M shares), BlackRock (~6.9%), State Street, Berkshire Hathaway, Geode, Morgan Stanley, Charles Schwab, Bank of America and Norges Bank.
  • Warren Buffett anchor stake: Berkshire Hathaway remains a top-five holder, a long-standing vote of confidence in CVX's capital discipline and dividend durability that lends the shareholder base stability.
  • Passive ownership concentration: Vanguard and BlackRock together control ~16% of the float; heavy index ownership provides liquidity and a steady bid but limits activist pressure.
  • Low insider ownership: Insiders hold just ~0.5% of shares — normal for a mega-cap; governance hinges on the institutional base rather than a founder block.
  • 13F posture — steady accumulation: Filings show broad index accumulation through the Hess close and dividend hike; the dividend-Aristocrat profile keeps CVX a core income holding across pension and income mandates.

Quantified Risk Assessment

Severity Risk Factor Prob. PT Impact
High Oil price reversion toward $79-90 55% -18%
High Elevated ~104% reported payout ratio 35% -12%
Medium Hess integration / Guyana execution 30% -10%
Medium Premium valuation vs cheaper majors 35% -10%
Low Energy-transition / demand risk 25% -6%
Low Geopolitical / regulatory shocks 25% -5%

Summary

Rating
BUY
Conviction
Med-High
Price Target
$211
Timeframe
12 mo
Upside
+16%
Position Size
3%-5%

Entry Strategy

1
Tranche 1 — 40%
~$182
Initiate near current levels; ~3.9% yield, Buy consensus and a ~$216 average target anchor an income-first entry above the 200-DMA.
2
Tranche 2 — 35%
~$173
Add at the 200-DMA on an oil-driven pullback, where the yield climbs above 4%.
3
Tranche 3 — 25%
~$160
Reserve for a deeper cyclical flush toward the lower support band to lock in a higher starting yield.
IMPORTANT DISCLAIMER: This analysis is for educational and research purposes only. Not financial advice. Past performance does not guarantee future results. Consult qualified financial professionals before making investment decisions. All investments carry risk of loss. The information presented is based on publicly available data as of May 31, 2026.